Compare RQI & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RQI | STAA |
|---|---|---|
| Founded | 2002 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2001 | 1995 |
| Metric | RQI | STAA |
|---|---|---|
| Price | $12.18 | $23.60 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $22.81 |
| AVG Volume (30 Days) | 480.2K | ★ 780.9K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 8.20% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | N/A | $8.41 |
| P/E Ratio | ★ N/A | $89.04 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.30 | $15.59 |
| 52 Week High | $13.57 | $35.87 |
| Indicator | RQI | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 38.94 | 44.32 |
| Support Level | $11.95 | $22.55 |
| Resistance Level | $12.29 | $26.21 |
| Average True Range (ATR) | 0.12 | 0.97 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 34.90 | 32.94 |
COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the fund is high current income through investment in real estate securities. The Fund's secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.